The user facility reported to terumo cardiovascular that during prime, the pigtail of the plegia port was clogged. *no patient involvement, *product was changed out, *procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations.The returned sample was visually inspected.No damages were present in the affected area of the product.No other visual anomalies were noted.A syringe filled with water was attached to the luer port at the end of the pigtail line, and then an attempt was made to push water through the line.This was unsuccessful confirming the blocked port.Additionally, water was placed into the blood outlet port of the oxygenator and attempted to be pulled through the pigtail line; this was also unsuccessful.A retention sample of the same product code and lot number combination was retrieved.Visual inspection of the retention sample concluded with no noted visual anomalies.The retention sample was tested with positive and negative flow through the pigtail line, and each attempt passed.The cause of the event is excess bonding agent on the tubing when it is inserted into the port, causing the bonding agent to be pushed down the outside of the tubing by the port.The bonding agent then dries on the outside of the tubing allowing it to block the port.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|